Marapharm Ventures Inc Stock Deutsche Boerse AG
Equities
CA56575M1086
Healthcare Facilities & Services
Sales 2020 | 2.27 2.11 | Sales 2021 | 3.15 2.93 | Capitalization | 10.06M 9.35M |
---|---|---|---|---|---|
Net income 2020 | -40M -37.17M | Net income 2021 | -8M -7.43M | EV / Sales 2020 | 13,592,488 x |
Net Debt 2020 | 5.3M 4.93M | Net Debt 2021 | 13.31M 12.37M | EV / Sales 2021 | 7,417,546 x |
P/E ratio 2020 |
-0.45
x | P/E ratio 2021 |
-1.08
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 71.26% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Searle
IRO | Public Communications Contact | - | - |
James O’Sullivan
SEC | Corporate Secretary | - | 20-11-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott R. Berman
BRD | Director/Board Member | - | - |
Dylan Rexing
BRD | Director/Board Member | - | 20-10-07 |
1st Jan change | Capi. | |
---|---|---|
+47.74% | 289M | |
+30.93% | 270M | |
+48.84% | 193M | |
-14.29% | 145M | |
+57.96% | 143M | |
-31.21% | 142M | |
+160.63% | 141M | |
-7.69% | 80.17M | |
+150.00% | 75.33M |